Stupp, R; Hegi, M E; Neyns, B; Goldbrunner, R; Schlegel, U; Clement, P M J; Grabenbauer, G G; Ochsenbein, A F; Simon, M; Dietrich, P Y; Pietsch, T; Hicking, C; Tonn, J C; Diserens, A C; Pica, A; Hermisson, M; Krueger, S; Picard, M; Weller, M (2010). Reply to M.C. Chamberlain. Journal of Clinical Oncology, 28(33):e696-e697.
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Downloads
Additional indexing
| Item Type: | Journal Article, refereed, further contribution |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology |
| Dewey Decimal Classification: | 610 Medicine & health |
| Scopus Subject Areas: | Health Sciences > Oncology
Life Sciences > Cancer Research |
| Language: | Italian |
| Date: | 2010 |
| Deposited On: | 28 Jan 2011 17:19 |
| Last Modified: | 28 Jun 2022 13:49 |
| Publisher: | American Society of Clinical Oncology |
| ISSN: | 0732-183X |
| Additional Information: | Reply to: Chamberlain, M C. What role should cilengitide have in the treatment of glioblastoma? J Clin Oncol. 2010 Nov 20;28(33):e695 |
| OA Status: | Closed |
| Free access at: | PubMed ID. An embargo period may apply. |
| Publisher DOI: | https://doi.org/10.1200/JCO.2010.31.2843 |
Stupp, R